Covid Vaccine IP: How Big Pharma lobbied against India

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......

In the works: Priority list of who will get Covid vaccine first

The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready. Image used for representational......

How long before the world gets a COVID-19 vaccine?

More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global......

Bon appetit Mr Modi!

'Make in India' will be central to Mr Modi's visit to Europe and Canada. It is difficult to predict what will happen with the Rafale deal, but if it goes through, it will undoubtedly become the......

Q3 result preview: US, India to aid revenue growth for Pharma Inc

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for......

Domestic pharma market grew by 6.8% in 2023

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Photograph: Amit......

India's pharma industry likely to take 5-6% price hikes this year

Notwithstanding the fact that the country’s pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential......

Biocon Biologics Plan Molecule Launch Every 1-2 Years

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.' Photograph: PTI Photo   The market share that Biocon......